Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients

Archives of Neurology

Volumn 67, Issue 5, 2010, Pages 589-595

  Weintraub, Daniel ^a,b   Koester, Juergen ^c   Potenza, Marc N ^d   Siderowf, Andrew D ^a   Stacy, Mark ^e   Voon, Valerie ^f,i   Whetteckey, Jacqueline ^g   Wunderlich, Glen R ^h   Lang, Anthony E ^f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^h BOEHRINGER INGELHEIM CANADA LTD   (Canada)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ADULT; AGE; AGED; ARTICLE; BINGE EATING DISORDER; CIGARETTE SMOKING; CLINICAL TRIAL; COMPULSION; COMPULSIVE BUYING; CROSS-SECTIONAL STUDY; DRUG USE; FAMILY HISTORY; FEMALE; HUMAN; IMPULSE CONTROL DISORDER; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; SINGLE MAN;

AGED; ANTIPARKINSON AGENTS; BENZOTHIAZOLES; BINGE-EATING DISORDER; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GAMBLING; HUMANS; IMPULSE CONTROL DISORDERS; INDOLES; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; RISK FACTORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 77952157407     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.65     Document Type: Article

References (35)

1. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol. 2007;64(8):1089-1096. (Pubitemid 47258066)
2. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol. 2006; 63(7):969-973. (Pubitemid 44036299)
3. Voon V, Hassan K, Zurowski M, et al. Prospective prevalence of pathological gambling and medication association in Parkinson disease. Neurology. 2006;66 (11):1750-1752. (Pubitemid 43964638)
4. Pontone G, Williams JR, Bassett SS, Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology. 2006;67(7):1258-1261. (Pubitemid 44563839)
5. Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfà F. Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord. 2006;21 (12):2068-2072. (Pubitemid 46140413)
6. Voon V, Hassan K, Zurowski M, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology. 2006;67(7):1254-1257. (Pubitemid 44563838)
7. Molina JA, Sáinz-Artiga MJ, Fraile A, et al. Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment? Mov Disord. 2000;15(5):869-872.
8. SmedingHMM,Goudriaan AE, Foncke EMJ, Schuurman PR, Speelman JD, Schmand B. Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J Neurol Neurosurg Psychiatry. 2007;78(5):517-519. (Pubitemid 46662902)
9. Shaffer HJ, LaBrie R, Scanlan KM, Cummings TN. Pathological gambling among adolescents: Massachusetts gambling screen (MAGS). J Gambl Stud. 1994; 10(4):339-362.
10. Christenson GA, Faber RJ, deZwaan M, et al. Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry. 1994;55(1):5-11.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
12. Fahn S, Elton RL; the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Health Care Information; 1987:153-163.
13. Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology. 2003;61(3):422-423. (Pubitemid 36975988)
14. Evans AH, Katzenschlager R, Paviour D, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord. 2004;19 (4):397-405. (Pubitemid 38559642)
15. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJL. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry. 2000;68(4):423-428.
16. Ondo WG, Lai D. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord. 2008;14(1):28-32.
17. Singh A, Kandimala G, Dewey RB Jr, O'Suilleabhain P. Risk factors for pathological gambling and other compulsions among Parkinson's disease patients taking dopamine agonists. J Clin Neurosci. 2007;14(12):1178-1181.
18. Koran LM, Faber RJ, Aboujaoude E, Large MD, Serpe RT. Estimated prevalence of compulsive buying behavior in the United States. Am J Psychiatry. 2006; 163(10):1806-1812.
19. Striegel-Moore RH, Franko DL. Epidemiology of binge eating disorder. Int J Eat Disord. 2003;34(suppl):S19-S29.
20. Kuzma JM, Black DW. Epidemiology, prevalence, and natural history of compulsive sexual behavior. Psychiatr Clin North Am. 2008;31(4):603-611.
21. Shaffer HJ, Hall MN, Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health. 1999;89(9):1369-1376.
22. Voon V, Thomsen T, Miyasaki JM, et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol. 2007; 64(2):212-216.
23. Gurevich EV, Joyce JN. Distribution of dopamine D3 receptor expression neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology. 1999;20(1):60-80.
24. Holden C. 'Behavioral' addictions: do they exist? Science. 2001;294(5544): 980-982.
25. Brewer JA, Potenza MN. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol. 2008;75(1): 63-75.
26. Gerlach M, Double K, Arzberger T, Leblhuber F, Tatschner T, Riederer P. Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum. J Neural Transm. 2003;110 (10):1119-1127.
27. Cunningham-Williams RM, Cottler LB, Compton WM III, Spitznagel EL. Taking chances: problem gamblers and mental health disorders: results from the St. Louis Epidemiologic Catchment Area Study. Am J Public Health. 1998;88(7): 1093-1096.
28. Grucza RA, Przybeck TR, Cloninger CR. Prevalence and correlates of binge eating disorder in a community sample. Compr Psychiatry. 2007;48(2):124-131.
29. Petry NM, Stinson FS, Grant BF. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on alcohol and related conditions. J Clin Psychiatry. 2005;66(5):564-574.
30. Slutske WS, Eisen S, True WR, Lyons MJ, Goldberg J, Tsuang M. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry. 2000;57(7):666-673.
31. Comings DE, Gonzalez N, Wu S, et al. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet. 1999;88(4):358-368.
32. Lilenfeld LRR, Ringham R, Kalarchian MA, Marcus MD. A family history study of binge-eating disorder. Compr Psychiatry. 2008;49(3):247-254.
33. Crockford D, Quickfall J, Currie S, Furtado S, Suchowersky O, el-Guebaly N. Prevalence of problem and pathological gambling in Parkinson's disease. J Gambl Stud. 2008;24(4):411-422.
34. Giladi N, Weitzman N, Schreiber S, Shabtai H, Peretz C. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset. J Psychopharmacol. 2007;21(5):501-506.
35. Holman AJ. Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia. J Gambl Stud. 2009;25(3):425-431. doi:10.1007/s10899-009-9123-2.